| 1. |
田家瑞, 金石, 金鉉順. 2017年美國ACC/AHA高血壓指南更新解讀. 中國心血管病研究, 2018, 16(10): 885-888.
|
| 2. |
孫英賢, 李玉明, 蔡軍, 等. 高血壓合并動脈粥樣硬化防治中國專家共識. 中華高血壓雜志, 2020, 28(2): 116-123.
|
| 3. |
Qi Y, Han X, Zhao D, et al. Long-term cardiovascular risk associated with stage 1 hypertension defined by the 2017 ACC/AHA hypertension guideline. J Am Coll Cardiol, 2018, 72(11): 1201-1210.
|
| 4. |
Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001, 24(4): 683-689.
|
| 5. |
Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European society of hypertension task force document. J Hypertens, 2009, 27(11): 2121-2158.
|
| 6. |
Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American college of cardiology foundation/American heart association task force on Practice Guidelines. Circulation, 2010, 122(25): 2748-2764.
|
| 7. |
Reference Values for Arterial Stiffness' Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J, 2010, 31(19): 2338-2350.
|
| 8. |
Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J, 2006, 27(21): 2588-2605.
|
| 9. |
華琦, 譚靜, 劉東霞, 等. 高血壓病患者頸-股動脈和頸-橈動脈脈搏波速度改變及其影響因素. 中華心血管病雜志, 2005, 33(12): 1088-1091.
|
| 10. |
馮雪, 劉俊明. 脈搏波傳導速度與高血壓相關性的研究進展. 臨床和實驗醫學雜志, 2013, 12(16): 1340-1341, 1343.
|